Prism Medico & Pharmacy Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 1.59 | 0.08 | 0.21 |
| Operating Expense | 0.94 | 0.06 | 0.22 |
| Net Profit | 0.66 | 0.04 | -0.01 |
| Net Profit Margin | 41.51 | 50 | -4.76 |
| Earning Per Share | 0.01 | TBA | TBA |
| EBIDTA | 0.66 | 0.04 | -0.01 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 1.59 |
| Operating Expense | 0.94 |
| Net Profit | 0.66 |
| Net Profit Margin | 41.51 |
| Earning Per Share | 0.01 |
| EBIDTA | 0.66 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 2.93 | 1.27 | 8.44 |
| Operating Expenses Annual | 3.06 | 1.37 | 8.93 |
| Operating Profit Annual | -0.02 | -0.10 | -0.49 |
| Interest Annual | 0.01 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.01 |
| Net Profit Annual | -0.02 | -0.08 | -0.37 |
| Tax Annual | -0.01 | -0.03 | -0.13 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 2.93 |
| Operating Expenses Annual | 3.06 |
| Operating Profit Annual | -0.02 |
| Interest Annual | 0.01 |
| Depreciation | 0.01 |
| Net Profit Annual | -0.02 |
| Tax Annual | -0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.10 | 0.06 | 0.08 |
| Cash Flow from Operations | -0.01 | 2.95 | -2.38 |
| Cash Flow from Investing | TBA | -2.91 | 2.35 |
| Cash Flow from Financing | -0.01 | TBA | TBA |
| Cash Flow at the End | 0.08 | 0.10 | 0.06 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.10 |
| Cash Flow from Operations | -0.01 |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | -0.01 |
| Cash Flow at the End | 0.08 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -0.34 | -7.87 | -5.81 |
| PBIT Margin (%) | -0.68 | -8.66 | -5.92 |
| PBT Margin (%) | 67.58 | -8.66 | -5.92 |
| Net PROFIT Margin (%) | -0.68 | -6.30 | -4.38 |
| Return On Networth / Equity (%) | -0.13 | -0.58 | -2.91 |
| Return On Networth /Employed (%) | -0.13 | -0.79 | -3.93 |
| Return On Assets (%) | -0.13 | -0.57 | -2.89 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.19 | 0.09 | 0.66 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -0.34 |
| PBIT Margin (%) | -0.68 |
| PBT Margin (%) | 67.58 |
| Net PROFIT Margin (%) | -0.68 |
| Return On Networth / Equity (%) | -0.13 |
| Return On Networth /Employed (%) | -0.13 |
| Return On Assets (%) | -0.13 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.19 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.03 | 0.03 | 0.05 |
| Total Current Assets Annual | 14.99 | 15.15 | 12.34 |
| Non Current Assets Annual | 0.25 | 0.25 | 0.23 |
| Total Shareholders Funds Annual | 15.14 | 15.16 | 12.55 |
| Total Assets Annual | 15.24 | 15.39 | 12.57 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.03 |
| Total Current Assets Annual | 14.99 |
| Non Current Assets Annual | 0.25 |
| Total Shareholders Funds Annual | 15.14 |
| Total Assets Annual | 15.24 |
EPS (INR)
Expected
0.00
Reported
-0.07
Surprise
0.00%
Sep 2019
EPS beaten by 0.00%
Jun 2019
EPS beaten by 0.00%
Mar 2019
EPS beaten by 0.00%
